Jiewu Liu, PhD
Director, Bioanalytical Science
Jiewu Liu is the Director of Bioanalytical Science at Kriya Therapeutics. Dr. Liu joins Kriya from Cambridge Biomedical, where he was an Associate Director and built and led a team to provide bioanalytical support for drug development under GxPs. He has over ten years of combined experience in bioanalytical assay development and validation. Before that, Dr. Liu served as bioanalysis manager at Enzyvant and its parent company Roivant Sciences where he was responsible for bioanalytical method development. Dr. Liu held positions of increasing responsibility at Vascular Pharmaceuticals, Argos Therapeutics, and BioAgilytix.
Dr. Liu received his PhD in biochemistry and molecular biology from the Shanghai Institute of Biochemistry and Cell Biology and completed his postdoctoral fellowships at St. Jude Children’s Hospital and Weill Medical College of Cornell University. Dr. Liu received his undergraduate degree in Biochemistry from Nankai University, China.